ガイドライン

(旧版)急性膵炎診療ガイドライン2010

書誌情報
第VII章  急性膵炎の重症度診断

 
引用文献

1) 大槻眞,武田和憲,松野正紀,他.急性膵炎重症度判定基準と診断基準の改訂.胆と膵2008; 29(4): 301-305.(診断レベル4)
2) 武田和憲,大槻眞,木原康之,他.急性膵炎重症度判定基準最終改訂案の検証.厚生労働科学研究費補助金難治性疾患克服研究事業難治性膵疾患に関する調査研究,平成19年度総括・分担研究報告書2008; 29-33.(診断レベル4)
3) 横江正道,真弓俊彦,林克巳.実地臨床における急性膵炎改訂重症度判定基準の検討.膵臓2009; 24(2): 140-146.(診断レベル4)
4) 厚生省特定疾患難治性膵疾患調査研究班.重症急性膵炎の病態.難病・重症急性膵炎‐診療の手引き,松野正紀監.医学図書出版,東京,1997; 2-3.(病因レベル4)
5) 林櫻松,玉腰暁子,大野良之,他.急性膵炎の全国疫学調査成績.厚生科学研究特定疾患対策研究事業特定疾患の疫学に関する研究班,平成11年度研究業績集2000; 72-78.(病因レベル4)
6) 大槻眞,伊藤鉄英,小泉勝,他.急性膵炎の救命率と重症化要因‐急性膵炎臨床調査の解析.膵臓2005; 20(1): 17-30.(予後レベル3b)
7) Banks PA, Freeman ML. Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101: 2379-2400.(診断レベル2b)
8) Forell MM. Die konservative Behandulung der Pankreaserkrankungen. Der Internist 1964; 5: 453-457.(診断レベル4)
9) Bank S, Wise L, Gersten M. Risk factors in acute pancreatitis. Am J Gastroenterol 1983; 78(10): 637-640.(診断レベル4)
10) Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978; 65(5): 337-341.(診断レベル1b)
11) 小川道雄,広田昌彦,早川哲夫,他.急性膵炎のStage 分類,小川道雄編.厚生省特定疾患消化器系疾患調査研究班難治性膵疾患分科会,平成10年度報告書1999; 19-22.(診断レベル4)
12) Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590.(診断レベル2b-5)
13) British Society of Gastroenterology. United Kingdom guidelines for the management of acute pancreatitis. Gut 1998; 42(Suppl 2): S1-S13.(診断レベル2b-5)
14) Corfield AP, Cooper MJ, Williamson RC, et al. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet 1985; 2(8452): 403-407.(診断レベル2b)
15) Working Party of the British Society of Gastroenterology. Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut 2005; 54(Suppl 3): iii1-iii9.
16) Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999; 25: 195-210.(診断レベル2b-5)
17) Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2(8656): 201-205.(診断レベル2b)
18) Viedma JA, Perez MM, Agullo J, et al. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994; 35(6): 822-827.(診断レベル1c)
19) Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995; 40(11): 2341-2348.(診断レベル2b)
20) Uchikov PA, Sirakova IP, Murdjeva MA, et al. Changes in plasma levels of acute phase proteins in pancreatitis. Folia Med(Plovdiv) 2000; 42(1): 23-30.(診断レベル2b)
21) Toouli J, Brooke-Smith M, Bassi C, et al. Working Party of the Program Commitee of the Bangkok World Congress of Gastroenterology 2002. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 2002; 17(Suppl): S15-S39.
22) 武田和憲.急性膵炎の診療ガイドライン‐重症度判定基準の問題点.膵臓2006; 21: 495-499.(診断レベル4)
23) Matsuda Y, Ogawa M, Nishijima J, et al. Usefulness of determination of serum immunoreactive pancreatic phospholipase A2 content for early identification of severe acute pancreatitis. Hepatogastroenterology 1986; 33(5): 214-216.(診断レベル2b)
24) Nevalainen TJ, Gronroos JM, Kortesuo PT. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 1993; 34(8): 1133-1136.(診断レベル3b)
25) Hietaranta A, Kemppainen E, Puolakkainen P, et al. Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome(SIRS) and systemic complications in severe acute pancreatitis. Pancreas 1999; 18(4): 385-391.(診断レベル2b)
26) Skipworth JR, Pereira SP. Acute pancreatitis. Curr Opin Crit Care 2008; 14(2): 172-178.(診断レベル5)
27) Brown A, James-Stevenson T, Dyson T, et al. The panc 3 score: a rapid and accurate test for predicting severity on presentation in acute pancreatitis. J Clin Gastroenterol 2007; 41(9): 855-858.(診断レベル2b)
28) Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin(PCT): a prospective international multicenter study. Ann Surg 2007; 245(5): 745-754.(診断レベル2b)
29) De Waele JJ, Blot S. The value of IL-6 in predicting the severity of acute pancreatitis. J Clin Gastroenterol 2007; 41(5): 534-535.(診断レベル5)
30) Sathyanarayan G, Garg PK, Prasad H, et al. Elevated level of interleukin-6 predicts organ failure and severe disease inpatients with acute pancreatitis. J Gastroenterol Hepatol 2007; 22(4): 550-554.(診断レベル4)
31) De Beaux A, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996; 83(3): 349-353.(診断レベル2b)
32) Hirota M, Nozawa F, Okabe A, et al. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000; 21(2): 141-146.(診断レベル2b)
33) Gross V, Scholmerich J, Leser HG, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci 1990; 35(1): 97-105. (診断レベル2b)
34) Uhl W, Buchler M, Malfertheiner P, et al. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6(3): 253-259.(診断レベル2b)
35) Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355(9219): 1955-1960.(診断レベル2b)
36) Heath DI, Wilson C, Gudgeon AM, et al. Trypsinogen activation peptides(TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994; 35(9): 1311-1315.(診断レベル1b)
37) Appelros S, Thim L, Borgstrom A. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998; 42(1): 97-102.(診断レベル4)
38) Ranson JH, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 1976; 143(2): 209-219.(診断レベル1b)
39) Lankisch PG, Schirren CA, Otto J. Methemalbumin in acute pancreatitis: an evaluation of its prognostic value and comparison with multiple prognostic parameters. Am J Gastroenterol 1989; 84(11): 1391-1395.(診断レベル2b)
40) Funnell IC, Bornman PC, Weakley SP, et al. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 1993; 80(4): 484-486.(診断レベル4)
41) Martinez J, Sanchez PJ, Palazon JM, et al. Obesity: a prognostic factor of severity in acute pancreatitis. Pancreas 1999; 19(1): 15-20.(診断レベル2c)
42) Tsai CJ. Is obesity a significant prognostic factor in acute pancreatitis? Dig Dis Sci 1998; 43(10): 2251-2254.(診断レベル2b)
43) Porter KA, Banks PA. Obesity as a predictor of severity in acute pancreatitis. Int J Pancreatol 1991; 10(3-4): 247-252.(診断レベル3b)
44) Martínez J, Sánchez-Payá J, Palazon JM, et al. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology 2004; 4(1): 42-48.(予後レベル1a)
45) Sempere L, Martinez J, de Madaria E, et al. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology 2008; 8: 257-264.(診断レベル4)
46) 広田昌彦,小川道雄.肥満と急性膵炎(Obesity in acute pancreatitis).肝胆膵2001; 42: 53-56.(診断レベル3b)
47) Yeung YP, Lam BY, Yip AW. APACHE system is better than Ranson system in the prediction of severity of acute pancreatitis. Hepatobiliary Pancreat Dis Int 2006; 5(2): 294-299.(診断レベル4)
48) Vesentini S, Bassi C, Talamini G, et al. Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993; 80: 755-757.(診断レベル1b)
49) Kemppainen E, Sainio V, Haapiainen R, et al. Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis. Br J Surg 1996; 83: 924-929.(診断レベル2b)
50) Bradley EL 3rd, Murphy F, Ferguson C. Prediction of pancreatic necrosis by dynamic pancreatography. Ann Surg 1989; 210: 495-503.(診断レベル3b)
51) Larvin M, Chalmers AG, McMahon MJ. Dynamic contrast enhanced computed tomography: a precise technique for identifying and localizing pancreatic necrosis. Br Med J 1990; 300: 1425-1428.(診断レベル1c)
52) Lytras D, Manes K, Triantopoulou C, et al. Persistent early organ failure: defining the high-risk group of patients with severe acute pancreatitis? Pancreas 2008; 36(3): 249-254.(診断レベル4)
53) Lin A, Feller ER. Pancreatic carcinoma as a cause of unexplained pancreatitis: report of ten cases. Ann Intern Med 1990; 112: 166-167.(診断レベル4)
54) Mujica VR, Barkin JS, Go VLW, et al. Acute pancreatitis secondary to pancreatic carcinoma. Pancreas 2000; 21: 329-332.(診断レベル3b)
55) Mortele KJ, Mergo PJ, Taylor HM, et al. Peripancreatic vascular abnormalities complicating acute pancreatitis: contrast-enhanced helical CT findings. Eur J Radiol 2004; 52(1): 67-72.(診断レベル3b)
56) Burke JW, Erickson AJ, Kellum CD, et al. Pseudoaneurysms complicating pancreatitis: detected by CT. Radiology 1986; 161: 447-450.(診断レベル4)
57) Balthazar EJ, Freeny PC, van Sonnenberg E. Imaging and intervention in acute pancreatitis. Radiology 1994; 193: 297-306.(診断レベル3b)
58) Vujic I, Andersen BL, Stanley JH, et al. Pancreatic and peripancreatic vessels: embolization for control of bleeding in pancreatitis. Radiology 1984; 150: 51-55.(診断レベル3b)
59) Waltman A, Luers P, Athanasoulis C, et al. Massive arterial hemorrhage in patients with pancreatitis: complementary roles of surgery and transcatheter occlusive techniques. Arch Surg 1986; 121: 439-443.(診断レベル3b)
60) Parvey HR, Raval B, Sandler CM. Portal vein thrombosis: imaging findings. AJR 1994; 162: 77-81.(診断レベル3b)
61) Carmona-Sánchez R, Uscanga L, Bezaury-Rivas P, et al. Potential harmful effect of iodinated intravenous contrast medium on the clinical course of mild acute pancreatitis. Arch Surg 2000; 135: 1280-1284.(診断レベル2a)
62) Hwang TL, Chang KY, Ho YP. Contrast-enhanced dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis. Reevaluation of the effect of intravenous contrast medium on the severity of acute pancreatitis. Arch Surg 2000; 135: 287-290.(診断レベル1b)
63) Uhl W, Roggo A, Kirschstein T, et al. Influence of contrast-enhanced computed tomography on course and outcome in patients with acute pancreatitis. Pancreas 2002; 24: 191-197.(診断レベル4)
64) 松野正紀,小川道雄,武田和憲,他.急性膵炎CT Grade分類の再検討‐全国集計症例からの解析による最終報告.厚生労働省特定疾患研究事業難治性膵疾患に関する調査研究班,平成12年度研究報告書2001; 19-26.(診断レベル4)
65) Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174(2): 331-336.(診断レベル1c)
66) 松野正紀,小川道雄,武田和憲,他.急性膵炎のCT grade分類の再検討‐全国集計症例からの解析.厚生省特定疾患対策研究事業難治性膵疾患に関する調査研究班,平成11年度研究報告書2000; 17-20.(診断レベル2b)
67) London NJ, Leese T, Lavelle JM, et al. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study. Br J Surg 1991; 78: 1452-1456.(診断レベル2b)
68) Clavien PA, Hauser H, Meyer P, et al. Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. Am J Surg 1988; 155: 457-466.(診断レベル2b)
69) Rotman N, Chevret S, Pezet D, et al. Prognostic value of early computed tomographic scans in severe acute pancreatitis. J Am Coll Surg 1994; 179: 538-544.(診断レベル2b)
70) Lecesne R, Taourel P, Bret PM, et al. Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology 1999; 211: 727-735.(診断レベル2b)
71) Talamini G, Bassi C, Falconi M, et al. Risk of death from acute pancreatitis. Role of early, simple "routine" data. Int J Pancreatol 1996; 19: 15-24.(診断レベル2b)
72) Maringahini A, Ciambra M, Patti R, et al. Ascites, pleural, and pericardial effusions in acute pancreatitis. A prospective study of incidence, natural history, and prognostic role. Dig Dis Sci 1996; 41: 848-852.(診断レベル2b)
73) Lankisch PG, Droge M, Becher R. Pulmonary infiltrations. Sign of severe acute pancreatitis. Int J Pancreatol 1966; 19(2): 113-115.(診断レベル2b)
74) Ranson JH, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139(1): 69-81.(診断レベル1b)
75) Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982; 77(9): 633-638.(診断レベル2a)
76) Osborne DH, Imrie CW, Carter DC. Biliary surgery in the same admission for gallstone-associated acute pancreatitis. Br J Surg 1981; 68(11): 758-761.(診断レベル2b)
77) Blamey SL, Imrie CW, O'Neill J, et al. Prognostic factors in acute pancreatitis. Gut 1984; 25(12): 1340-1346. (診断レベル1b)
78) Damman HG, Dopner M, Wichert PV, et al. Die beurteilung der fruhprognose der akuten pankrestitis. Zentralbl Chir 1981; 106: 154-160.(診断レベル1b-3b)
79) Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.(診断レベル1b)
80) Bollen TL, van Santvoort HC, Besselink MG, et al. The Atlanta Classification of acute pancreatitis revisited. Br J Surg 2008; 95: 6-21(診断レベル1a)
81) 水本龍二,大藤正雄,高田忠敬,他.急性膵炎の診断基準・重症度判定基準の再検討(画像診断の評価を含めて).厚生省特定疾患難治性膵疾患調査研究班,平成元年度研究報告書1991; 18-26.(診断レベル3b)

 

書誌情報